TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/24 16:15 | 8/14/24 | MURA | Mural Oncology Plc | L2 | Health | Drug | Pharmaceutical Preparations | Altschuller Susan | L2 | D | P | 32 | 3.21 | 0 | 10 | New | 10 | D | |||||||||||||||
12/21/23 20:12 | 12/19/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Altschuller Susan | MA | O | CFO | M.d | 0 | 0.00 | 0 | 31 | 17 | D | |||||||||||||||
12/21/23 20:12 | 12/20/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Altschuller Susan | MA | O | CFO | S.d | -572 | 41.42 | 0 | -14 | -45 | 17 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |